📣 Introducing Tracenable Pro: Unlock Unlimited Data Exports & Disclosures Access.

Recordati Industria Chimica e Farmaceutica SpA

Common Name
Recordati
Country
Italy
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
4,495
Ticker
REC
Exchange
EURONEXT MILAN
Description
Recordati Industria Chimica e Farmaceutica S.p.A. is a prominent pharmaceutical company known for its development, manufacturing, and marketing of pharmaceuticals and pharmaceutical chemicals. The com...

Recordati's Financial Statements Preview

Below are the financial statements of Recordati, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Interested in getting early access to our real-time standardized financial datafeed?
Learn More
All figures in millions of EUR
2024
2023
Net revenue
2,341.56a
2,082.33a
Cost of sales
-741.29a
-659.71a
Gross profit
1,600.27a
1,422.62a
Selling expenses
-497.73a
-472.86a
Research and development expenses
-286.03a
-255.75a
General and administrative expenses
-156.65a
-128.25a
Other income/(expenses), net
-21.01a
-7.76a
Operating income
638.86a
558.01a
Financial income/(expenses), net
-91.67a
-66.97a
Pre-tax income
547.18a
491.04a
Income taxes
-130.68a
-101.82a
Net income
416.51a
389.21a
Attributable to——
Equity holders of the parent
416.51a
389.21a
Non-controlling interests
0a
0a
Download Data

Verified Sources Behind Recordati’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Recordati’s data sources below and access millions more through our Disclosure Search.

a. Recordati's Financial Report 2024
a. Recordati's Financial Report 2024
Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

Tracenable is building real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?